Glycaemic control and cardiovascular outcome trials in type 2 diabetes

Clifford  J. Bailey; Caroline Day; Ian W. Campbell; Christoph Schindler

doi:10.1177/1474651412458958

Glycaemic control and cardiovascular outcome trials in type 2 diabetes

Clifford J. Bailey
, Caroline Day
, Ian W. Campbell
, Christoph Schindler

Technische Universität Dresden
University of St. Andrews
Aston University

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Large prospective trials designed to assess the relationship between metabolic control and CV outcomes in type 2 diabetes have entered a new phase of scrutiny due to strict requirements imposed by the FDA to assess new anti-diabetic agents. So what have we learned from recently completed trials and what do we expect to learn from on-going trials?

Original language	English
Pages (from-to)	161-164
Number of pages	4
Journal	British Journal of Diabetes and Vascular Disease
Volume	12
Issue number	4
DOIs	https://doi.org/10.1177/1474651412458958
Publication status	Published - Jul 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1177/1474651412458958

Cite this

@article{aeaa26668f9e407784d1d24f8301c2bc,

title = "Glycaemic control and cardiovascular outcome trials in type 2 diabetes",

abstract = "Large prospective trials designed to assess the relationship between metabolic control and CV outcomes in type 2 diabetes have entered a new phase of scrutiny due to strict requirements imposed by the FDA to assess new anti-diabetic agents. So what have we learned from recently completed trials and what do we expect to learn from on-going trials? ",

author = "Bailey, \{Clifford J.\} and Caroline Day and Campbell, \{Ian W.\} and Christoph Schindler",

year = "2012",

month = jul,

doi = "10.1177/1474651412458958",

language = "English",

volume = "12",

pages = "161--164",

journal = "British Journal of Diabetes and Vascular Disease",

issn = "1474-6514",

publisher = "SAGE",

number = "4",

}

TY - JOUR

T1 - Glycaemic control and cardiovascular outcome trials in type 2 diabetes

AU - Bailey, Clifford J.

AU - Day, Caroline

AU - Campbell, Ian W.

AU - Schindler, Christoph

PY - 2012/7

Y1 - 2012/7

N2 - Large prospective trials designed to assess the relationship between metabolic control and CV outcomes in type 2 diabetes have entered a new phase of scrutiny due to strict requirements imposed by the FDA to assess new anti-diabetic agents. So what have we learned from recently completed trials and what do we expect to learn from on-going trials?

AB - Large prospective trials designed to assess the relationship between metabolic control and CV outcomes in type 2 diabetes have entered a new phase of scrutiny due to strict requirements imposed by the FDA to assess new anti-diabetic agents. So what have we learned from recently completed trials and what do we expect to learn from on-going trials?

UR - https://www.scopus.com/pages/publications/84866511170

UR - http://dvd.sagepub.com/content/12/4/161

U2 - 10.1177/1474651412458958

DO - 10.1177/1474651412458958

M3 - Article

AN - SCOPUS:84866511170

SN - 1474-6514

VL - 12

SP - 161

EP - 164

JO - British Journal of Diabetes and Vascular Disease

JF - British Journal of Diabetes and Vascular Disease

IS - 4

ER -

Glycaemic control and cardiovascular outcome trials in type 2 diabetes

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this